Denali Therapeutics Ownership | Who Owns Denali Therapeutics?

Denali Therapeutics Ownership Summary

Denali Therapeutics is owned by 74.56% institutional investors, 9.64% insiders, and 15.81% retail investors. Baillie gifford is the largest institutional shareholder, holding 9.21% of DNLI shares. Vanguard Health Care Inv is the top mutual fund, with 6.14% of its assets in Denali Therapeutics shares.

DNLI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Denali Therapeutics	74.56%	9.64%	15.81%
Sector	Healthcare Stocks	46.62%	8.13%	45.25%
Industry	Biotech Stocks	44.91%	7.98%	47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baillie gifford	13.76M	9.21%	$319.59M
Blackrock	13.17M	8.82%	$305.91M
Vanguard group	11.31M	7.57%	$262.67M
Wellington management group llp	9.82M	6.58%	$228.11M
Capital research global investors	7.13M	4.77%	$165.48M
Temasek (private)	5.71M	3.82%	$132.50M
Crestline management, lp	4.76M	3.19%	$110.54M
State street	4.43M	2.97%	$102.98M
Baker bros. advisors lp	3.73M	2.50%	$86.65M
Geode capital management	2.98M	2.00%	$69.27M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Crestline management, lp	4.76M	8.60%	$110.54M
Casdin capital	1.30M	2.30%	$30.19M
Yiheng capital management	1.15M	2.15%	$26.72M
Stempoint capital lp	251.01K	1.71%	$5.83M
Camber capital management lp	2.00M	1.29%	$46.44M
Baker bros. advisors lp	3.73M	1.11%	$86.65M
Clarius group	410.00K	0.67%	$9.52M
Temasek (private)	5.71M	0.62%	$132.50M
Pier capital	165.49K	0.57%	$3.84M
Ironwood investment management	36.23K	0.45%	$841.24K

Top Buyers

Holder	Shares	% Assets	Change
Alliancebernstein	2.02M	0.02%	1.88M
Ubs asset management americas	2.30M	0.02%	1.61M
Wellington management group llp	9.82M	0.04%	1.55M
Capital research global investors	7.13M	0.04%	1.08M
Point72 asset management	1.05M	0.06%	1.05M

Top Sellers

Holder	Shares	% Assets	Change
State street	4.43M	0.00%	-1.89M
Flagship pioneering	-	-	-1.36M
Gilder gagnon howe	-	-	-1.17M
Fmr	234.87K	0.00%	-997.65K
Holocene advisors, lp	59.04K	0.01%	-801.91K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	823.94K	0.00%	823.94K	$19.13M
Stempoint capital lp	251.01K	1.71%	251.01K	$5.83M
Cinctive capital management lp	112.32K	0.12%	112.32K	$2.61M
Northwest & ethical investments	75.83K	0.05%	75.83K	$1.76M
Mirae asset global etfs	74.70K	0.00%	74.70K	$1.73M

Sold Out

Holder	Change
Cibc private wealth group	-1.00
Innealta capital	-30.00
Financial synergies wealth advisors	-36.00
Naples money management	-45.00
Valley national advisers	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	220	6.80%	126,341,996	5.65%	74	1.49%	116	1.75%	57	-5.00%
Jun 30, 2024	204	-3.77%	119,583,732	2.39%	80	1.11%	113	2.73%	59	-13.24%
Mar 31, 2024	212	-2.75%	116,796,834	5.49%	85	1.31%	110	3.77%	68	-2.86%
Dec 31, 2023	218	10.66%	110,718,414	2.75%	80	1.30%	106	-0.93%	70	22.81%
Sep 30, 2023	197	-1.99%	107,756,975	0.01%	78	1.26%	107	-2.73%	57	7.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Health Care Inv	8.80M	6.14%	1.12M
Scottish Mortgage Ord	6.53M	4.56%	-
American Funds SMALLCAP World A	5.98M	4.18%	703.00K
Baillie Gifford US Equity Growth	3.51M	2.45%	-
Vanguard US Growth Investor	3.51M	2.45%	-
Vanguard Total Stock Mkt Idx Inv	3.31M	2.30%	-21.51K
iShares Russell 2000 ETF	3.19M	2.22%	-7.18K
Vanguard Small Cap Index	2.69M	1.87%	5.25K
Vanguard Institutional Extnd Mkt Idx Tr	1.86M	1.30%	-83.97K
Fidelity Growth Compy Commingled Pl S	1.69M	1.18%	354.48K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 11, 2024	Schenkein David P	-	Sell	$1.06M
Nov 11, 2024	Schenkein David P	-	Sell	$870.57K
Nov 07, 2024	Schuth Alexander O.	COFO and Secretary	Sell	$366.04K
Nov 07, 2024	Schuth Alexander O.	COFO and Secretary	Sell	$89.86K
Nov 07, 2024	Schuth Alexander O.	COFO and Secretary	Sell	$9.39K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	8
2024 Q3	-	18
2024 Q2	-	5
2024 Q1	-	15
2023 Q4	-	3

DNLI Ownership FAQ

Who Owns Denali Therapeutics?

Denali Therapeutics shareholders are primarily institutional investors at 74.56%, followed by 9.64% insiders and 15.80% retail investors. The average institutional ownership in Denali Therapeutics's industry, Biotech Stocks , is 44.91%, which Denali Therapeutics exceeds.

Who owns the most shares of Denali Therapeutics?

Denali Therapeutics’s largest shareholders are Baillie gifford (13.76M shares, 9.21%), Blackrock (13.17M shares, 8.82%), and Vanguard group (11.31M shares, 7.57%). Together, they hold 25.60% of Denali Therapeutics’s total shares outstanding.

Does Blackrock own Denali Therapeutics?

Yes, BlackRock owns 8.82% of Denali Therapeutics, totaling 13.17M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 305.91M$. In the last quarter, BlackRock increased its holdings by 974.71K shares, a 7.99% change.

Who is Denali Therapeutics’s biggest shareholder by percentage of total assets invested?

Crestline management, lp is Denali Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.60% of its assets in 4.76M Denali Therapeutics shares, valued at 110.54M$.

Who is the top mutual fund holder of Denali Therapeutics shares?

Vanguard Health Care Inv is the top mutual fund holder of Denali Therapeutics shares, with 6.14% of its total shares outstanding invested in 8.8M Denali Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools